 | • レポートコード：D0GIR-01020 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、黄斑浮腫治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。黄斑浮腫治療の種類別市場規模（レーザー治療、抗VEGF注射、抗炎症治療、硝子体切除術）、用途別市場規模（嚢胞性黄斑浮腫（CME）、糖尿病性黄斑浮腫（DME））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Allergan、Bausch & Lomb、Regeneron Pharmaceuticals、Novartis、Boehringer Ingelheim、Roche、ActiveSite Pharmaceuticals、Bayer、Pfizer、Aciont、Astellas Pharma、Adverum Biotechnologies、Araim Pharmaceuticals、Aerpio Therapeutics、Ampio Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・黄斑浮腫治療の北米市場（アメリカ、カナダ、メキシコ） ・黄斑浮腫治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・黄斑浮腫治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・黄斑浮腫治療の南米市場（ブラジル、アルゼンチン） ・黄斑浮腫治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：レーザー治療、抗VEGF注射、抗炎症治療、硝子体切除術 ・用途別分析：嚢胞性黄斑浮腫（CME）、糖尿病性黄斑浮腫（DME） ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Macular Edema Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Macular Edema Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Macular Edema Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Macular Edema Therapeutics market has been segmented into:
Laser Treatment
Anti-VEGF Injection
Anti-Inflammatory Treatment
Vitrectomy
By Application, Macular Edema Therapeutics has been segmented into:
Cystoid Macular Edema (CME)
Diabetic Macular Edema(DME)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Macular Edema Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Macular Edema Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Macular Edema Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Macular Edema Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Macular Edema Therapeutics Market Share Analysis
Macular Edema Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Macular Edema Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Macular Edema Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Macular Edema Therapeutics are:
Allergan
Bausch & Lomb
Regeneron Pharmaceuticals
Novartis
Boehringer Ingelheim
Roche
ActiveSite Pharmaceuticals
Bayer
Pfizer
Aciont
Astellas Pharma
Adverum Biotechnologies
Araim Pharmaceuticals
Aerpio Therapeutics
Ampio Pharmaceuticals
Table of Contents
1 Macular Edema Therapeutics Market Overview
1.1 Product Overview and Scope of Macular Edema Therapeutics
1.2 Classification of Macular Edema Therapeutics by Type
1.2.1 Global Macular Edema Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Macular Edema Therapeutics Revenue Market Share by Type in 2019
1.2.3 Laser Treatment
1.2.4 Anti-VEGF Injection
1.2.5 Anti-Inflammatory Treatment
1.2.6 Vitrectomy
1.3 Global Macular Edema Therapeutics Market by Application
1.3.1 Overview: Global Macular Edema Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cystoid Macular Edema (CME)
1.3.3 Diabetic Macular Edema(DME)
1.4 Global Macular Edema Therapeutics Market by Regions
1.4.1 Global Macular Edema Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Macular Edema Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Macular Edema Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Macular Edema Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Macular Edema Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Macular Edema Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Macular Edema Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bausch & Lomb
2.2.1 Bausch & Lomb Details
2.2.2 Bausch & Lomb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bausch & Lomb SWOT Analysis
2.2.4 Bausch & Lomb Product and Services
2.2.5 Bausch & Lomb Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Regeneron Pharmaceuticals
2.3.1 Regeneron Pharmaceuticals Details
2.3.2 Regeneron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Regeneron Pharmaceuticals SWOT Analysis
2.3.4 Regeneron Pharmaceuticals Product and Services
2.3.5 Regeneron Pharmaceuticals Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Boehringer Ingelheim SWOT Analysis
2.5.4 Boehringer Ingelheim Product and Services
2.5.5 Boehringer Ingelheim Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 ActiveSite Pharmaceuticals
2.7.1 ActiveSite Pharmaceuticals Details
2.7.2 ActiveSite Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 ActiveSite Pharmaceuticals SWOT Analysis
2.7.4 ActiveSite Pharmaceuticals Product and Services
2.7.5 ActiveSite Pharmaceuticals Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer SWOT Analysis
2.8.4 Bayer Product and Services
2.8.5 Bayer Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aciont
2.10.1 Aciont Details
2.10.2 Aciont Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Aciont SWOT Analysis
2.10.4 Aciont Product and Services
2.10.5 Aciont Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Astellas Pharma
2.11.1 Astellas Pharma Details
2.11.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Astellas Pharma SWOT Analysis
2.11.4 Astellas Pharma Product and Services
2.11.5 Astellas Pharma Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Adverum Biotechnologies
2.12.1 Adverum Biotechnologies Details
2.12.2 Adverum Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Adverum Biotechnologies SWOT Analysis
2.12.4 Adverum Biotechnologies Product and Services
2.12.5 Adverum Biotechnologies Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Araim Pharmaceuticals
2.13.1 Araim Pharmaceuticals Details
2.13.2 Araim Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Araim Pharmaceuticals SWOT Analysis
2.13.4 Araim Pharmaceuticals Product and Services
2.13.5 Araim Pharmaceuticals Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Aerpio Therapeutics
2.14.1 Aerpio Therapeutics Details
2.14.2 Aerpio Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Aerpio Therapeutics SWOT Analysis
2.14.4 Aerpio Therapeutics Product and Services
2.14.5 Aerpio Therapeutics Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Ampio Pharmaceuticals
2.15.1 Ampio Pharmaceuticals Details
2.15.2 Ampio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Ampio Pharmaceuticals SWOT Analysis
2.15.4 Ampio Pharmaceuticals Product and Services
2.15.5 Ampio Pharmaceuticals Macular Edema Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Macular Edema Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Macular Edema Therapeutics Players Market Share
3.2.2 Top 10 Macular Edema Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Macular Edema Therapeutics Revenue and Market Share by Regions
4.2 North America Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Macular Edema Therapeutics Revenue by Countries
5.1 North America Macular Edema Therapeutics Revenue by Countries (2015-2020)
5.2 USA Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Macular Edema Therapeutics Revenue by Countries
6.1 Europe Macular Edema Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Macular Edema Therapeutics Revenue by Countries
7.1 Asia-Pacific Macular Edema Therapeutics Revenue by Countries (2015-2020)
7.2 China Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Macular Edema Therapeutics Revenue by Countries
8.1 South America Macular Edema Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Macular Edema Therapeutics by Countries
9.1 Middle East & Africa Macular Edema Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Macular Edema Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Macular Edema Therapeutics Market Forecast by Type (2019-2024)
10.3 Laser Treatment Revenue Growth Rate (2015-2025)
10.4 Anti-VEGF Injection Revenue Growth Rate (2015-2025)
10.5 Anti-Inflammatory Treatment Revenue Growth Rate (2015-2025)
10.6 Vitrectomy Revenue Growth Rate (2015-2025)
11 Global Macular Edema Therapeutics Market Segment by Application
11.1 Global Macular Edema Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Macular Edema Therapeutics Market Forecast by Application (2019-2024)
11.3 Cystoid Macular Edema (CME) Revenue Growth (2015-2020)
11.4 Diabetic Macular Edema(DME) Revenue Growth (2015-2020)
12 Global Macular Edema Therapeutics Market Size Forecast (2021-2025)
12.1 Global Macular Edema Therapeutics Market Size Forecast (2021-2025)
12.2 Global Macular Edema Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Macular Edema Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Macular Edema Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Macular Edema Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Macular Edema Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Allergan Corporate Information, Location and Competitors
Table 6. Allergan Macular Edema Therapeutics Major Business
Table 7. Allergan Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Allergan SWOT Analysis
Table 9. Allergan Macular Edema Therapeutics Product and Solutions
Table 10. Allergan Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bausch & Lomb Corporate Information, Location and Competitors
Table 12. Bausch & Lomb Macular Edema Therapeutics Major Business
Table 13. Bausch & Lomb Macular Edema Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Bausch & Lomb SWOT Analysis
Table 15. Bausch & Lomb Macular Edema Therapeutics Product and Solutions
Table 16. Bausch & Lomb Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Regeneron Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Regeneron Pharmaceuticals Macular Edema Therapeutics Major Business
Table 19. Regeneron Pharmaceuticals Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Regeneron Pharmaceuticals SWOT Analysis
Table 21. Regeneron Pharmaceuticals Macular Edema Therapeutics Product and Solutions
Table 22. Regeneron Pharmaceuticals Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Macular Edema Therapeutics Major Business
Table 25. Novartis Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Macular Edema Therapeutics Product and Solutions
Table 28. Novartis Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 30. Boehringer Ingelheim Macular Edema Therapeutics Major Business
Table 31. Boehringer Ingelheim Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Boehringer Ingelheim SWOT Analysis
Table 33. Boehringer Ingelheim Macular Edema Therapeutics Product and Solutions
Table 34. Boehringer Ingelheim Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Corporate Information, Location and Competitors
Table 36. Roche Macular Edema Therapeutics Major Business
Table 37. Roche Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Roche SWOT Analysis
Table 39. Roche Macular Edema Therapeutics Product and Solutions
Table 40. Roche Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. ActiveSite Pharmaceuticals Corporate Information, Location and Competitors
Table 42. ActiveSite Pharmaceuticals Macular Edema Therapeutics Major Business
Table 43. ActiveSite Pharmaceuticals Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. ActiveSite Pharmaceuticals SWOT Analysis
Table 45. ActiveSite Pharmaceuticals Macular Edema Therapeutics Product and Solutions
Table 46. ActiveSite Pharmaceuticals Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bayer Corporate Information, Location and Competitors
Table 48. Bayer Macular Edema Therapeutics Major Business
Table 49. Bayer Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Bayer SWOT Analysis
Table 51. Bayer Macular Edema Therapeutics Product and Solutions
Table 52. Bayer Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Pfizer Corporate Information, Location and Competitors
Table 54. Pfizer Macular Edema Therapeutics Major Business
Table 55. Pfizer Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Pfizer SWOT Analysis
Table 57. Pfizer Macular Edema Therapeutics Product and Solutions
Table 58. Pfizer Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Aciont Corporate Information, Location and Competitors
Table 60. Aciont Macular Edema Therapeutics Major Business
Table 61. Aciont Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Aciont SWOT Analysis
Table 63. Aciont Macular Edema Therapeutics Product and Solutions
Table 64. Aciont Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Astellas Pharma Corporate Information, Location and Competitors
Table 66. Astellas Pharma Macular Edema Therapeutics Major Business
Table 67. Astellas Pharma Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Astellas Pharma SWOT Analysis
Table 69. Astellas Pharma Macular Edema Therapeutics Product and Solutions
Table 70. Astellas Pharma Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Adverum Biotechnologies Corporate Information, Location and Competitors
Table 72. Adverum Biotechnologies Macular Edema Therapeutics Major Business
Table 73. Adverum Biotechnologies Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 74. Adverum Biotechnologies SWOT Analysis
Table 75. Adverum Biotechnologies Macular Edema Therapeutics Product and Solutions
Table 76. Adverum Biotechnologies Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Araim Pharmaceuticals Corporate Information, Location and Competitors
Table 78. Araim Pharmaceuticals Macular Edema Therapeutics Major Business
Table 79. Araim Pharmaceuticals Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 80. Araim Pharmaceuticals SWOT Analysis
Table 81. Araim Pharmaceuticals Macular Edema Therapeutics Product and Solutions
Table 82. Araim Pharmaceuticals Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Aerpio Therapeutics Corporate Information, Location and Competitors
Table 84. Aerpio Therapeutics Macular Edema Therapeutics Major Business
Table 85. Aerpio Therapeutics Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 86. Aerpio Therapeutics SWOT Analysis
Table 87. Aerpio Therapeutics Macular Edema Therapeutics Product and Solutions
Table 88. Aerpio Therapeutics Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Ampio Pharmaceuticals Corporate Information, Location and Competitors
Table 90. Ampio Pharmaceuticals Macular Edema Therapeutics Major Business
Table 91. Ampio Pharmaceuticals Macular Edema Therapeutics Total Revenue (USD Million) (2017-2018)
Table 92. Ampio Pharmaceuticals SWOT Analysis
Table 93. Ampio Pharmaceuticals Macular Edema Therapeutics Product and Solutions
Table 94. Ampio Pharmaceuticals Macular Edema Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Macular Edema Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 96. Global Macular Edema Therapeutics Revenue Share by Players (2015-2020)
Table 97. Global Macular Edema Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Macular Edema Therapeutics Revenue Market Share by Regions (2015-2020)
Table 99. North America Macular Edema Therapeutics Revenue by Countries (2015-2020)
Table 100. North America Macular Edema Therapeutics Revenue Market Share by Countries (2015-2020)
Table 101. Europe Macular Edema Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Macular Edema Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Macular Edema Therapeutics Revenue by Countries (2015-2020)
Table 104. South America Macular Edema Therapeutics Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Macular Edema Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Macular Edema Therapeutics Revenue Market Share by Countries (2015-2020)
Table 107. Global Macular Edema Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 108. Global Macular Edema Therapeutics Revenue Share by Type (2015-2020)
Table 109. Global Macular Edema Therapeutics Revenue Forecast by Type (2021-2025)
Table 110. Global Macular Edema Therapeutics Revenue by Application (2015-2020)
Table 111. Global Macular Edema Therapeutics Revenue Share by Application (2015-2020)
Table 112. Global Macular Edema Therapeutics Revenue Forecast by Application (2021-2025)
Table 113. Global Macular Edema Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Macular Edema Therapeutics Picture
Figure 2. Global Macular Edema Therapeutics Revenue Market Share by Type in 2019
Figure 3. Laser Treatment Picture
Figure 4. Anti-VEGF Injection Picture
Figure 5. Anti-Inflammatory Treatment Picture
Figure 6. Vitrectomy Picture
Figure 7. Macular Edema Therapeutics Revenue Market Share by Application in 2019
Figure 8. Cystoid Macular Edema (CME) Picture
Figure 9. Diabetic Macular Edema(DME) Picture
Figure 10. Global Macular Edema Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Macular Edema Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Macular Edema Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Macular Edema Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Macular Edema Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Macular Edema Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Macular Edema Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Macular Edema Therapeutics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Macular Edema Therapeutics Revenue Market Share in 2019
Figure 19. Global Top 10 Players Macular Edema Therapeutics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Macular Edema Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Macular Edema Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 23. Global Macular Edema Therapeutics Revenue Market Share by Regions in 2018
Figure 24. North America Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Europe Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. South America Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. North America Macular Edema Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 30. North America Macular Edema Therapeutics Revenue Market Share by Countries in 2019
Figure 31. USA Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Canada Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Europe Macular Edema Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Macular Edema Therapeutics Revenue Market Share by Countries in 2019
Figure 36. Germany Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. UK Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. France Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Russia Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Italy Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Macular Edema Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Macular Edema Therapeutics Revenue Market Share by Countries in 2019
Figure 43. China Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Japan Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Korea Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. India Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. South America Macular Edema Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 49. South America Macular Edema Therapeutics Revenue Market Share by Countries in 2019
Figure 50. Brazil Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Macular Edema Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Macular Edema Therapeutics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. UAE Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Macular Edema Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Global Macular Edema Therapeutics Revenue Share by Type (2015-2020)
Figure 59. Global Macular Edema Therapeutics Revenue Share by Type in 2019
Figure 60. Global Macular Edema Therapeutics Market Share Forecast by Type (2021-2025)
Figure 61. Global Laser Treatment Revenue Growth Rate (2015-2020)
Figure 62. Global Anti-VEGF Injection Revenue Growth Rate (2015-2020)
Figure 63. Global Anti-Inflammatory Treatment Revenue Growth Rate (2015-2020)
Figure 64. Global Vitrectomy Revenue Growth Rate (2015-2020)
Figure 65. Global Macular Edema Therapeutics Revenue Share by Application (2015-2020)
Figure 66. Global Macular Edema Therapeutics Revenue Share by Application in 2019
Figure 67. Global Macular Edema Therapeutics Market Share Forecast by Application (2021-2025)
Figure 68. Global Cystoid Macular Edema (CME) Revenue Growth Rate (2015-2020)
Figure 69. Global Diabetic Macular Edema(DME) Revenue Growth Rate (2015-2020)
Figure 70. Global Macular Edema Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Macular Edema Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Macular Edema Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. Europe Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. South America Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Macular Edema Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
若年性黄斑変性症（シュタルガルト病）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Juvenile Macular Degeneration (Stargardt Disease) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx millio…- 加齢黄斑変性症（AMD）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Age Related Macular Degeneration (AMD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1608.8 million by 2025, from USD 1348.9 million in 2019. T…
- 黄斑変性薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Macular Degeneration Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Macular Degenerati…
- 黄斑変性症（AMD）・糖尿病性網膜症（DR）薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mil…
- 抗炎症治療剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-inflammatory Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 81620 million by 2025, from USD 63230 million in 2019. The Anti-in…